Combined blockade of PI3K/AKT and EGFR/HER3 enhances antitumor activity in triple negative breast cancer

被引：0
|
作者：
Scaltriti, Maurizio [1 ]
Tao, Jessica [2 ]
Juric, Dejan [2 ]
Auricchio, Neil [2 ]
Castel, Pau [1 ]
Morse, Natasha [1 ]
Kim, Phillip [3 ]
Singh, Sharat [3 ]
Hazra, Saswati [3 ]
Hembrough, Todd [4 ]
Burrows, Jon [4 ]
Baselga, Jose [1 ]
机构：
[1] Mem Sloan Kettering Canc Ctr, New York, NY USA
[2] Massachusetts Gen Hosp, Ctr Canc, Boston, MA 02114 USA
[3] Prometheus Lab Therapeut & Diagnost, San Diego, CA USA
[4] OncoPlexDx, Rockville, MD USA
来源：
CANCER RESEARCH | 2013年 / 73卷 / 08期
关键词：
D O I：
10.1158/1538-7445.AM2013-4471
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
4471
引用
收藏
页数：1
相关论文
共 50 条
  • [21] HER2 Amplification in Tumors Activates PI3K/Akt Signaling Independent of HER3
    Ruiz-Saenz, Ana
    Dreyer, Courtney
    Campbell, Marcia R.
    Steri, Veronica
    Gulizia, Nate
    Moasser, Mark M.
    CANCER RESEARCH, 2018, 78 (13) : 3645 - 3658
  • [22] Rethink of EGFR signaling in triple negative breast cancer, with its interconnection with MAPK and PI3K/AKT signaling using bioinformatic approaches
    Braicu, Cornelia
    Jurj, Ancuta
    Zanoaga, Oana
    Lajos, Raduly
    Berindan-Neagoe, Ioana
    EUROPEAN JOURNAL OF HUMAN GENETICS, 2023, 31 : 637 - 637
  • [23] Rujifang inhibits triple-negative breast cancer growth via the PI3K/ AKT pathway
    Jia, Wenyu
    Lin, Xuan
    Chen, Xuezhang
    Li, Hongliang
    Zhang, Xingru
    Zhang, Yuzhuo
    Chen, Yinsong
    Wang, Bin
    Chen, Xikang
    Chen, Ju
    Tian, Huaqin
    JOURNAL OF ETHNOPHARMACOLOGY, 2024, 327
  • [24] Triple negative breast cancer: shedding light onto the role of pi3k/akt/mtor pathway
    Massihnia, Daniela
    Galvano, Antonio
    Fanale, Daniele
    Perez, Alessandro
    Castiglia, Marta
    Incorvaia, Lorena
    Listi, Angela
    Rizzo, Sergio
    Cicero, Giuseppe
    Bazan, Viviana
    Castorina, Sergio
    Russo, Antonio
    ONCOTARGET, 2016, 7 (37) : 60712 - 60722
  • [25] Novel tumor suppressor regulating the PI3K/AKT pathway in triple negative breast cancer (TNBC)
    Chan, Stefanie
    Smith, Emma
    Monti, Stefano
    Cardamone, M. Dafne
    Perissi, Valentina
    CANCER RESEARCH, 2020, 80 (04)
  • [26] Piperine enhances doxorubicin sensitivity in triple-negative breast cancer by targeting the PI3K/Akt/mTOR pathway and cancer stem cells
    Hakeem, Andrew N.
    El-Kersh, Dina M.
    Hammam, Olfat
    Elhosseiny, Aliaa
    Zaki, Amr
    Kamel, Kohinour
    Yasser, Lidia
    Barsom, Marina
    Ahmed, Menatallah
    Gamal, Mohamed
    Attia, Yasmeen M.
    SCIENTIFIC REPORTS, 2024, 14 (01):
  • [27] Simultaneous Inhibition of EGFR and PI3K Enhances Radiosensitivity in Human Breast Cancer
    Li, Ping
    Zhang, Qing
    Torossian, Artour
    Li, Zhao-bin
    Xu, Wen-cai
    Lu, Bo
    Fu, Shen
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2012, 83 (03): : E391 - E397
  • [28] The PI3K/AKT/MTOR signaling pathway: The role of PI3K and AKT inhibitors in breast cancer
    Huemer F.
    Bartsch R.
    Gnant M.
    Current Breast Cancer Reports, 2014, 6 (2) : 59 - 70
  • [29] The interplay of HER2/HER3/PI3K and EGFR/HER2/PLC-γ1 signalling in breast cancer cell migration and dissemination
    Balz, Lydia M.
    Bartkowiak, Kai
    Andreas, Antje
    Pantel, Klaus
    Niggemann, Bernd
    Zaenker, Kurt S.
    Brandt, Burkhard H.
    Dittmar, Thomas
    JOURNAL OF PATHOLOGY, 2012, 227 (02): : 234 - 244
  • [30] Metformin synergistically enhances antitumor activity of cisplatin in gallbladder cancer via the PI3K/AKT/ERK pathway
    Bi, Tingting
    Zhu, Ao
    Yang, Xufeng
    Qiao, Huiying
    Tang, Jinmei
    Liu, Yan
    Lv, Rong
    CYTOTECHNOLOGY, 2018, 70 (01) : 439 - 448
12345